Champions Oncology, Inc. beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12027 FY2027 | — | — | — | Miss |
| Q42026 FY2026 | — | $-0.05 | — | Miss |
| Q32026 FY2026 | $0.09 | $-0.02 | -122.2% | Miss |
Back to CSBR overview · CSBR holders · CSBR KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.